These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 375434)

  • 1. Desensitization of patients with bee sting allergy using pure bee venom.
    Abkiewicz C; Lomnitzer R; Rabson AR
    S Afr Med J; 1979 Feb; 55(8):285-7. PubMed ID: 375434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and therapeutic aspects in the treatment of bee venom allergy].
    Wenz W; Friedrich B; Diener C; Schlenvoigt G; Jäger L; Strümpfel R
    Z Gesamte Inn Med; 1984 Nov; 39(21):530-3. PubMed ID: 6523947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
    van der Brempt X; Ledent C; Mairesse M
    Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bee venom immunotherapy - how early is it effective?
    Goldberg A; Confino-Cohen R
    Allergy; 2010 Mar; 65(3):391-5. PubMed ID: 19839973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Course of rapid hyposensitization with insect venom with special reference to local reaction, as a contribution to risk reduction].
    Fender G; Veltman G
    Z Hautkr; 1983 Mar; 58(6):357-68. PubMed ID: 6845803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hymenoptera venom allergy in humans.
    Cichocka-Jarosz E
    Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bee venom immunotherapy: clinical and immunologic observations.
    Bar-Sela S; Levo Y
    Ann Allergy; 1981 Dec; 47(6):460-3. PubMed ID: 7325420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bee-venom allergy in children: long-term predictive value of standardized challenge tests.
    Schuetze GE; Forster J; Hauk PJ; Friedl K; Kuehr J
    Pediatr Allergy Immunol; 2002 Feb; 13(1):18-23. PubMed ID: 12000494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J; Lonsdorf G; Schury W; Burg G
    MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
    [No Abstract]   [Full Text] [Related]  

  • 19. Bee venom immunotherapy.
    Oswald H
    Inforum; 1990; 11():10-1. PubMed ID: 2210838
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term efficacy of venom immunotherapy.
    Hafner T; DuBuske L; Kosnik M
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):162-5. PubMed ID: 18320918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.